ADC Therapeutics SA Announces FDA Approval of ZYNLONTA™ - Conference Call Transcript
.
Thank you for holding. Good afternoon, and welcome to the ADC Therapeutics ZYNLONTA FDA Approval Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.
At this time, I'd like to turn the call over to Amanda Hamilton, Investor Relations Manager at ADC Therapeutics. Please proceed.
Thank you, operator.
This afternoon, we issued a press release announcing the FDA approval of Lonca, which is now known as ZYNLONTA. This release is available on the ADCT website at ir.adctherapeutics.com under the Press Release's section.
On today's call are Chris Martin, Chief Executive Officer; Jay Feingold, Chief Medical Officer; and Jennifer Herron, Chief Commercial Officer. In addition, Jen Creel, our Chief Financial Officer, will join for the Q&A session.
As a reminder, this conference call may contain forward-looking statements. Such statements are subject to risks and uncertainties. We refer you to the section
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
